EVI1 was found to regulate the cancer stem cell (CSC)-associated properties of NPC cells via binding to the β-catenin promoter and subsequent activation and expression of β-catenin and the Wnt/β-catenin downstream target AXIN2 [3]. This evidence concerns the gene MECOM and cancer.